FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Related Tags >> Eli Lilly   prasugrel   FDA   Effient
Syndicate content

Daiichi Sankyo News

Most Popular Daiichi Sankyo Story

FDA again delays prasugrel decision

Analysts were in for a surprise with the news that the FDA is once again delaying any decision on prasugrel, a potential blockbuster... Read more...

Latest Headlines